HomePSTV • NASDAQ
add
Plus Therapeutics Inc
Previous close
$1.60
Day range
$1.52 - $1.67
Year range
$0.97 - $5.09
Market cap
7.12M USD
Avg Volume
28.46K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 1.31M | 769.54% |
Operating expense | 2.38M | -33.64% |
Net income | -3.81M | 32.66% |
Net profit margin | -290.18 | 92.26% |
Earnings per share | -0.70 | 70.83% |
EBITDA | -3.71M | 31.48% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 8.55M | -52.79% |
Total assets | 11.39M | -52.29% |
Total liabilities | 12.74M | -26.90% |
Total equity | -1.35M | — |
Shares outstanding | 4.28M | — |
Price to book | -5.33 | — |
Return on assets | -78.25% | — |
Return on capital | -192.27% | — |
Cash Flow
Net change in cash
(USD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -3.81M | 32.66% |
Cash from operations | -1.88M | 15.80% |
Cash from investing | -42.00K | -281.82% |
Cash from financing | -529.00K | -634.34% |
Net change in cash | -2.45M | -14.26% |
Free cash flow | -2.28M | -23.35% |
About
Plus Therapeutics, Inc. is a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for adults and children with rare and difficult-to-treat cancers. The company is headquartered in Austin, Texas, United States. Wikipedia
Founded
1996
Headquarters
Website
Employees
20